Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide

Gynecologic Oncology

Volumn 60, Issue 3, 1996, Pages 438-442

  Chambers, Joseph T ^a   Chambers, Setsuko K ^a   Kohorn, Ernest I ^a   Carcangiu, Maria Luisa ^a,b   Schwartz, Peter E ^a  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; LORAZEPAM; ONDANSETRON; PROCHLORPERAZINE MALEATE;

ABDOMINAL ABSCESS; ADULT; AGED; ALOPECIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; FEVER; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPENIA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SEPSIS; URINARY TRACT INFECTION; UTERUS CARCINOMA;

EID: 0029919299     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0070     Document Type: Article

References (19)

1. Hendrickson, M., Ross, J., Eifel, P., Martinez, A., and Kempson, R. Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma, Am. J. Surg. Pathol. 6, 93-108 (1982).
2. Chambers, J. T., Merino, M., Kohorn, E. I., Peschel, R. E., and Schwartz, P. E. Uterine papillary serous carcinoma, Obstet. Gynecol. 69, 109-113 (1987).
3. Sutton, G. P., Brill, L., Michael, H., Stehman, F. B., and Ehrlich, C. E. Malignant papillary lesions of the endometrium, Gynecol. Oncol. 27, 373-392 (1987).
4. Silva, E. G., and Jenkins, R. Serous carcinoma in endometrial polyps, Mod. Pathol. 3, 120-128 (1990).
5. Carcangiu, M. L., and Chambers, J. T. Uterine papillary serous carcinoma: A study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma, Gynecol. Oncol. 47, 298-305 (1992).
6. Carcangiu, M. L., and Chambers, J. T. Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: Comparison of clinicopathologic features and survival, Int. J. Gynecol. Pathol. 14, 30-38 (1995).
7. Frank, A. H., Tseng, P., Haffty, B. G., Papadopolous, D. P., Kacinski, B., Dowling, S., Carcangiu, M. L., Kohorn, E. I., Chambers, J. T., Chambers, S. K., Peschel, R. E., and Schwartz, P. E. Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinoma, Cancer 68, 1516-1519 (1991).
8. Sorbe, B., Wolmesjö, E., and Frankendal, B. VM-26-vincristine-cisplatin combination chemotherapy in the treatment of primary advanced and recurrent endometrial carcinoma, Obstet. Gynecol. 73, 343-348 (1989).
9. Burke, T. W., Stringer, C. A., Morris, M., Freedman, R. S., Gershenson, D. M., Kavanagh, J. J., and Edwards, C. L. Prospective Treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide, Gynecol. Oncol. 40, 264-267 (1991).
10. Stringer, C. A., Gershenson, D. M., Burke, T. W., Edwards, C. L., Gordon, A. N., and Wharton, J. T. Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: A preliminary analysis, Gynecol. Oncol. 38, 305-308 (1990).
11. Levenback, C., Burke, T., Silva, E., Morris, M., Gershenson, D., Kavanagh, J., and Wharton, J. T. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC), Gynecol. Oncol. 46, 317-321 (1992).
12. Rosenberg, P., Boeryd, B., and Simonsen, E. A new aggressive approach to high-grade endometrial cancer of possible benefit to patients with stage I uterine papillary cancer, Gynecol. Oncol. 48, 32-37 (1993).
13. Price, F. V., Chambers, S. K., Carcangiu, M. L., Kohorn, M. D., Schwartz, P. E., and Chambers, J. T. Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC), Gynecol. Oncol. 51, 383-389 (1983).
14. Gibbons, S., Martinez, A., Schray, M., Podratz, K., Stanhope, R., Garton, G., Weiner, S., Brabbins, D., and Malkasian, G. Adjuvant whole abdominopelvic irradiation for high risk endometrial carcinoma, Int. J. Radiat. Oncol. Biol. Phys. 21, 1019-1025.
15. Mallipeddi, P., Kapp, D. S., and Teng, N. N. H. Long-term survival with adjuvant whole abdominopelvic irradiation for uterine papillary serous carcinoma, Cancer 71, 3076-3081.
16. International Federation of Gynecology and Obstetrics (FIGO). Annual report on the results of treatment in gynecologic cancer (F. Pettersson, Ed.), Panorama Press, Stockholm (1988).
17. DCI/NCI common toxicity criteria, July 1989, pp. 6-9.
18. Kaplan, E., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457-481 (1958).
19. Christman, J. E., Kapp, D. S., Hendrickson, M. R., Howes, A. E., and Ballon, S. C. Therapeutic approaches to uterine papillary serous carcinoma: A preliminary report, Gynecol. Oncol. 26, 228-235 (1987).